The Tecan Group has acquired Wako Automation assets, including the Director™ scheduling software, to enhance its laboratory automation capabilities and strengthen its market position.

Target Information

The Tecan Group, based in Männedorf, Switzerland, has successfully acquired the assets of Wako Automation, which include the prominent Director™ scheduling software and selected hardware modules. This transaction was finalized on December 1, 2025, and represents a significant leap for Tecan in expanding its capabilities within laboratory automation.

Tecan aims to enhance its portfolio by integrating advanced scheduling solutions that facilitate more flexible and efficient management of complex laboratory workflows. By incorporating Wako Automation's key technologies, Tecan intends to offer comprehensive solutions that synergize with its existing liquid handling platforms, such as the Fluent series.

Industry Overview

The laboratory automation industry in Switzerland is characterized by rapid technological advancement and increasing adoption of automation solutions across various sectors, particularly in life sciences a

View Source

Similar Deals

Galenica Labor Team Group

2025

Other Pharmaceuticals (NEC) Switzerland
Galderma Galderma shares

2025

Other Pharmaceuticals (NEC) Switzerland
Galenica Labor Team Gruppe

2025

Other Pharmaceuticals (NEC) Switzerland
Addex Therapeutics Stalicla

2025

Other Proprietary & Advanced Pharmaceuticals Switzerland
Sonova SilentCloud™

2025

Other Healthcare Facilities & Services (NEC) Switzerland
Sandoz Just-Evotec Biologics EU SAS

2025

Other Biopharmaceuticals Switzerland

Tecan Group

invested in

Wako Automation

in 2025

in a Other deal

Disclosed details

Revenue: $1,062M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert